{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:52:47Z","timestamp":1785577967940,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Research and Development Program of Hubei Province","award":["2024BCB053"],"award-info":[{"award-number":["2024BCB053"]}]},{"name":"Hubei Provincial Natural Science Foundation of China","award":["2024AFB063"],"award-info":[{"award-number":["2024AFB063"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82404022"],"award-info":[{"award-number":["82404022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hubei Provincial Postdoctoral Innovation Talent Training Program","award":["2024HBBHCXB023"],"award-info":[{"award-number":["2024HBBHCXB023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01801-0","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T02:51:43Z","timestamp":1752807103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of a fibroblast-derived gene signature reveals prognostic and therapeutic insights in pancreatic cancer"],"prefix":"10.1007","volume":"25","author":[{"given":"Wenjia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"1801_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073995","volume":"383","author":"M Del Chiaro","year":"2023","unstructured":"Del Chiaro M, Sugawara T, Karam SD, Messersmith WA. Advances in the management of pancreatic cancer. BMJ. 2023;383: e073995. https:\/\/doi.org\/10.1136\/bmj-2022-073995.","journal-title":"BMJ"},{"key":"1801_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326:851\u201362. https:\/\/doi.org\/10.1001\/jama.2021.13027.","journal-title":"JAMA"},{"key":"1801_CR3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, di Magliano MP, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186(8):1729\u201354. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014.","journal-title":"Cell"},{"key":"1801_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"1801_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1158\/2159-8290.CD-22-0876","volume":"13","author":"C Falcomata","year":"2023","unstructured":"Falcomata C, et al. Context-specific determinants of the immunosuppressive tumor microenvironment in pancreatic cancer. Cancer Discov. 2023;13:278\u201397. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0876.","journal-title":"Cancer Discov"},{"key":"1801_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00281-022-00962-4","volume":"45","author":"D Huynh","year":"2023","unstructured":"Huynh D, Winter P, Markl F, Endres S, Kobold S. Beyond direct killing-novel cellular immunotherapeutic strategies to reshape the tumor microenvironment. Semin Immunopathol. 2023;45:215\u201327. https:\/\/doi.org\/10.1007\/s00281-022-00962-4.","journal-title":"Semin Immunopathol"},{"key":"1801_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-024-01561-6","volume":"17","author":"P Farhangnia","year":"2024","unstructured":"Farhangnia P, Khorramdelazad H, Nickho H, Delbandi AA. Current and future immunotherapeutic approaches in pancreatic cancer treatment. J Hematol Oncol. 2024;17:40. https:\/\/doi.org\/10.1186\/s13045-024-01561-6.","journal-title":"J Hematol Oncol"},{"issue":"891\u2013908","key":"1801_CR8","doi-asserted-by":"publisher","first-page":"e814","DOI":"10.1053\/j.gastro.2023.05.036","volume":"165","author":"S Yousuf","year":"2023","unstructured":"Yousuf S, et al. Spatially resolved multi-omics single-cell analyses inform mechanisms of immune dysfunction in pancreatic cancer. Gastroenterology. 2023;165(891\u2013908):e814. https:\/\/doi.org\/10.1053\/j.gastro.2023.05.036.","journal-title":"Gastroenterology"},{"key":"1801_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho WJ, Jaffee EM, Zheng L. The tumour microenvironment in pancreatic cancer\u2014clinical challenges and opportunities. Nat Rev Clin Oncol. 2020;17:527\u201340. https:\/\/doi.org\/10.1038\/s41571-020-0363-5.","journal-title":"Nat Rev Clin Oncol"},{"key":"1801_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12967-024-05238-z","volume":"22","author":"YJ Zhong","year":"2024","unstructured":"Zhong YJ, et al. Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma. J Transl Med. 2024;22:422. https:\/\/doi.org\/10.1186\/s12967-024-05238-z.","journal-title":"J Transl Med"},{"key":"1801_CR11","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.7150\/ijbs.94868","volume":"20","author":"R Cai","year":"2024","unstructured":"Cai R, et al. A high immune-related index with the suppression of cGAS-STING pathway is a key determinant to Herceptin resistance in HER2+ breast cancer. Int J Biol Sci. 2024;20:3497\u2013514. https:\/\/doi.org\/10.7150\/ijbs.94868.","journal-title":"Int J Biol Sci"},{"key":"1801_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12967-023-04056-z","volume":"21","author":"Z Tan","year":"2023","unstructured":"Tan Z, et al. Comprehensive analysis of scrna-seq and bulk rna-seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. J Transl Med. 2023;21:223. https:\/\/doi.org\/10.1186\/s12967-023-04056-z.","journal-title":"J Transl Med"},{"key":"1801_CR13","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ccell.2024.08.005","volume":"42","author":"I Tirosh","year":"2024","unstructured":"Tirosh I, Suva ML. Cancer cell states: lessons from ten years of single-cell RNA-sequencing of human tumors. Cancer Cell. 2024;42:1497\u2013506. https:\/\/doi.org\/10.1016\/j.ccell.2024.08.005.","journal-title":"Cancer Cell"},{"key":"1801_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100498","volume":"3","author":"S Morabito","year":"2023","unstructured":"Morabito S, Reese F, Rahimzadeh N, Miyoshi E, Swarup V. hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep Methods. 2023;3: 100498. https:\/\/doi.org\/10.1016\/j.crmeth.2023.100498.","journal-title":"Cell Rep Methods"},{"key":"1801_CR15","doi-asserted-by":"publisher","first-page":"1331841","DOI":"10.3389\/fimmu.2024.1331841","volume":"15","author":"W Chen","year":"2024","unstructured":"Chen W, et al. A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis. Front Immunol. 2024;15:1331841. https:\/\/doi.org\/10.3389\/fimmu.2024.1331841.","journal-title":"Front Immunol"},{"key":"1801_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.106186","volume":"151","author":"J Cheng","year":"2022","unstructured":"Cheng J, et al. An immune-related gene signature for the prognosis of human bladder cancer based on WGCNA. Comput Biol Med. 2022;151: 106186. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106186.","journal-title":"Comput Biol Med"},{"key":"1801_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.973974","volume":"13","author":"Z He","year":"2022","unstructured":"He Z, et al. Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA. Front Immunol. 2022;13: 973974. https:\/\/doi.org\/10.3389\/fimmu.2022.973974.","journal-title":"Front Immunol"},{"key":"1801_CR18","doi-asserted-by":"publisher","first-page":"1132424","DOI":"10.3389\/fonc.2023.1132424","volume":"13","author":"J Chen","year":"2023","unstructured":"Chen J, Liu Z, Wu Z, Li W, Tan X. Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer. Front Oncol. 2023;13:1132424. https:\/\/doi.org\/10.3389\/fonc.2023.1132424.","journal-title":"Front Oncol"},{"key":"1801_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12967-023-04051-4","volume":"21","author":"K Chen","year":"2023","unstructured":"Chen K, et al. Immune profiling and prognostic model of pancreatic cancer using quantitative pathology and single-cell RNA sequencing. J Transl Med. 2023;21:210. https:\/\/doi.org\/10.1186\/s12967-023-04051-4.","journal-title":"J Transl Med"},{"key":"1801_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133562","volume":"10","author":"DT Chen","year":"2015","unstructured":"Chen DT, et al. Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma. PLoS ONE. 2015;10: e0133562. https:\/\/doi.org\/10.1371\/journal.pone.0133562.","journal-title":"PLoS ONE"},{"key":"1801_CR21","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1158\/1078-0432.CCR-16-0511","volume":"22","author":"J Wang","year":"2016","unstructured":"Wang J, et al. Endothelial nitric oxide synthase traffic inducer (NOSTRIN) is a negative regulator of disease aggressiveness in pancreatic cancer. Clin Cancer Res. 2016;22:5992\u20136001. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0511.","journal-title":"Clin Cancer Res"},{"key":"1801_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42:293\u2013304. https:\/\/doi.org\/10.1038\/s41587-023-01767-y.","journal-title":"Nat Biotechnol"},{"key":"1801_CR23","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using cell chat. Nat Commun. 2021;12:1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"key":"1801_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"key":"1801_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9: e107468. https:\/\/doi.org\/10.1371\/journal.pone.0107468.","journal-title":"PLoS ONE"},{"key":"1801_CR26","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.gpb.2022.12.004","volume":"21","author":"L Ma","year":"2023","unstructured":"Ma L, et al. Database commons: a catalog of worldwide biological databases. Genom Proteom Bioinf. 2023;21:1054\u20138. https:\/\/doi.org\/10.1016\/j.gpb.2022.12.004.","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"1801_CR27","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ccell.2024.08.011","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords L, de Souza N, Bodenmiller B. Classifying cancer-associated fibroblasts-the good, the bad, and the target. Cancer Cell. 2024;42:1480\u20135. https:\/\/doi.org\/10.1016\/j.ccell.2024.08.011.","journal-title":"Cancer Cell"},{"key":"1801_CR28","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1200\/JCO.18.01295","volume":"37","author":"RK Ramanathan","year":"2019","unstructured":"Ramanathan RK, et al. Phase IB\/II randomized study of FOLFIRINOX plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: SWOG S1313. J Clin Oncol. 2019;37:1062\u20139. https:\/\/doi.org\/10.1200\/JCO.18.01295.","journal-title":"J Clin Oncol"},{"key":"1801_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","volume":"17","author":"F Zhang","year":"2024","unstructured":"Zhang F, et al. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. J Hematol Oncol. 2024;17:80. https:\/\/doi.org\/10.1186\/s13045-024-01600-2.","journal-title":"J Hematol Oncol"},{"key":"1801_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.molmed.2023.03.002","volume":"29","author":"R Rebelo","year":"2023","unstructured":"Rebelo R, Xavier CPR, Giovannetti E, Vasconcelos MH. Fibroblasts in pancreatic cancer: molecular and clinical perspectives. Trends Mol Med. 2023;29:439\u201353. https:\/\/doi.org\/10.1016\/j.molmed.2023.03.002.","journal-title":"Trends Mol Med"},{"key":"1801_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-021-00271-4","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Cell Discov. 2021;7:36. https:\/\/doi.org\/10.1038\/s41421-021-00271-4.","journal-title":"Cell Discov"},{"key":"1801_CR32","doi-asserted-by":"publisher","first-page":"1242909","DOI":"10.3389\/fimmu.2023.1242909","volume":"14","author":"W Xu","year":"2023","unstructured":"Xu W, et al. Unveiling the role of regulatory T cells in the tumor microenvironment of pancreatic cancer through single-cell transcriptomics and in vitro experiments. Front Immunol. 2023;14:1242909. https:\/\/doi.org\/10.3389\/fimmu.2023.1242909.","journal-title":"Front Immunol"},{"key":"1801_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12967-024-05158-y","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X, et al. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer. J Transl Med. 2024;22:393. https:\/\/doi.org\/10.1186\/s12967-024-05158-y.","journal-title":"J Transl Med"},{"key":"1801_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12935-022-02469-2","volume":"22","author":"J Lu","year":"2022","unstructured":"Lu J, et al. A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma. Cancer Cell Int. 2022;22:38. https:\/\/doi.org\/10.1186\/s12935-022-02469-2.","journal-title":"Cancer Cell Int"},{"key":"1801_CR35","doi-asserted-by":"publisher","first-page":"23243","DOI":"10.1038\/s41598-024-74336-1","volume":"14","author":"Y Si","year":"2024","unstructured":"Si Y, Zhao Z, Meng X, Zhao K. RNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signature. Sci Rep. 2024;14:23243. https:\/\/doi.org\/10.1038\/s41598-024-74336-1.","journal-title":"Sci Rep"},{"key":"1801_CR36","doi-asserted-by":"publisher","first-page":"1201755","DOI":"10.3389\/fendo.2023.1201755","volume":"14","author":"Y Xu","year":"2023","unstructured":"Xu Y, Chen X, Liu N, Chu Z, Wang Q. Identification of fibroblast-related genes based on single-cell and machine learning to predict the prognosis and endocrine metabolism of pancreatic cancer. Front Endocrinol (Lausanne). 2023;14:1201755. https:\/\/doi.org\/10.3389\/fendo.2023.1201755.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1801_CR37","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.7150\/jca.100194","volume":"15","author":"S Zhang","year":"2024","unstructured":"Zhang S, et al. Identification and validation of a prognostic signature based on fibroblast immune-related genes to predict the prognosis and therapeutic response of renal clear cell carcinoma by integrated analysis of single-cell and bulk RNA sequencing data. J Cancer. 2024;15:5942\u201355. https:\/\/doi.org\/10.7150\/jca.100194.","journal-title":"J Cancer"},{"key":"1801_CR38","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2025.12038","author":"N Zhang","year":"2025","unstructured":"Zhang N, et al. Machine learning integration of single-cell and bulk transcriptomics identifies fibroblast-driven prognostic markers in colorectal cancer. Biomol Biomed. 2025. https:\/\/doi.org\/10.17305\/bb.2025.12038.","journal-title":"Biomol Biomed"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01801-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01801-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01801-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:50:13Z","timestamp":1764917413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01801-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1801"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01801-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval of the research protocol by an Institutional Reviewer Board: N\/A. Informed Consent: N\/A. Registry and the Registration No. of the study\/trial: N\/A. Animal Studies: N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"253"}}